CLAL Biotechnology Industries Ltd. Logo

CLAL Biotechnology Industries Ltd.

A life sciences VC firm financing and supporting innovative biotech & healthcare ventures.

CBI | TA

Overview

Corporate Details

ISIN(s):
IL0011042806
LEI:
Country:
Israel
Address:
Triangle Building 45th flr., 67023 Tel Aviv
Sector:
Financial and insurance activities
Industry:
Activities of trusts, funds and similar financial entities

Description

Clal Biotechnology Industries Ltd. (CBI) is a leading life sciences investment company and venture capital firm founded in 1998. CBI specializes in identifying, financing, and supporting innovative ventures within the biotechnology and healthcare sectors. Its investment strategy focuses on biopharmaceutical, diagnostic, and medical device companies that develop proprietary solutions to address significant unmet medical needs with high market potential. The firm actively manages its portfolio companies, providing strategic support to foster their growth from early-stage development through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-01-08 10:01
Investor Presentation
Corporate Presentation, January 2023
English 3.1 MB
2023-01-08 10:01
Regulatory Filings
Corporate Presentation, January 2023
Russian 41.8 KB
2021-02-14 15:58
Investor Presentation
CBI-Presentation-February 2021
English 2.4 MB
2021-02-14 15:58
Pre-Annual General Meeting Information
CBI-Presentation-February 2021
Russian 43.2 KB
2020-11-22 11:19
Investor Presentation
INVESTORS PRESENTATION,NOVEMBER 10,2020
English 1.9 MB
2020-11-22 11:19
AGM Information
INVESTORS PRESENTATION,NOVEMBER 10,2020
Russian 43.3 KB
2020-08-24 11:54
Investor Presentation
CORPORATE PRESENTATION AUGUST 2020
English 1.7 MB
2020-08-24 11:54
Regulatory Filings
CORPORATE PRESENTATION AUGUST 2020
Russian 43.2 KB

Automate Your Workflow. Get a real-time feed of all CLAL Biotechnology Industries Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CLAL Biotechnology Industries Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CLAL Biotechnology Industries Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eurazeo SE Logo
A global private markets investor in equity, debt & real assets, funding startups to mid-caps.
France
RF
EURO CERVANT Logo
A Spanish REIT acquiring and developing urban real estate for lease, also investing in other REITs.
Spain
YEUR
EURO KAPİTAL YATIRIM ORTAKLIĞI A.Ş. Logo
An investment trust managing diversified portfolios of global capital market instruments.
Türkiye
EUKYO
EURO MENKUL KIYMET YATIRIM ORTAKLIĞI A.Ş. Logo
A securities investment trust that actively manages a diversified portfolio to minimize risk for shareholders.
Türkiye
EUYO
EUROPEAN ASSETS TRUST PLC Logo
Invests in undervalued small & mid-cap European companies (ex-UK) for long-term capital growth.
United Kingdom
EAT
EUROPEAN EQUITY FUND, INC / MD Logo
A closed-end fund investing in a portfolio of European equities for long-term capital growth.
United States of America
EEA
EUROPEAN GREEN TRANSITION PLC Logo
Invests in undervalued European green economy assets via M&A to generate shareholder returns.
United Kingdom
EGT
European Healthcare Acquisition & Growth Company B.V. Logo
A SPAC acquiring European healthcare firms in biotech, pharma, and medtech.
Germany
EHCS
European Opportunities Trust Logo
A trust investing in high-quality European companies for long-term capital growth.
United Kingdom
EWI

Talk to a Data Expert

Have a question? We'll get back to you promptly.